Sugi Predict

Sugi Predict / Compounds / SCHEMBL862870

SCHEMBL862870

SCHEMBL862870

O=C(O)c1cc(OCc2ccccc2)cc(C(=O)O)c1

nearest known ligand 0.93

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ MEN1 O00255 1/20 0.93
▸ KMT2A Q03164 1/20 0.93
▸ NR4A2 P43354 5/20 0.75
▸ NR4A1 P22736 1/20 0.71
▸ NR4A3 Q92570 1/20 0.71
▸ SRD5A2 P31213 2/20 0.65
▸ MAOB P27338 2/20 0.61
▸ PLA2G4B P0C869 1/20 0.61
▸ GCK P35557 1/20 0.58
▸ TSHR P16473 1/20 0.58
▸ SMN1; SMN2 Q16637 1/20 0.58
▸ MRGPRX4 Q96LA9 1/20 0.58
▸ SMPD1 P17405 1/20 0.58
▸ PARP10 Q53GL7 1/20 0.57
▸ NR1H4 Q96RI1 1/20 0.57
▸ P2RY14 Q15391 1/20 0.57

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1426961 0.96 MEN1 (1.00) MEN1KMT2ANR4A2NR4A1NR4A3
Hydrochloric Acid SCHEMBL6841086 0.95 MEN1 (0.96) MEN1KMT2ANR4A2NR4A1NR4A3
SCHEMBL31141980 0.92 MEN1 (0.79) MEN1KMT2ANR4A2NR4A1NR4A3
SCHEMBL2570286 0.91 MEN1 (0.84) MEN1KMT2ANR4A2NR4A1NR4A3
SCHEMBL27585892 0.91 MEN1 (0.77) MEN1KMT2ANR4A2NR4A1NR4A3
SCHEMBL8900859 0.90 MEN1 (0.76) MEN1KMT2ANR4A2NR4A1NR4A3
SCHEMBL3129603 0.89 MEN1 (0.74) MEN1KMT2ANR4A2NR4A1NR4A3
SCHEMBL11694194 0.89 MEN1 (0.74) MEN1KMT2ANR4A2NR4A1NR4A3
SCHEMBL18687040 0.89 MEN1 (0.74) MEN1KMT2ANR4A2NR4A1NR4A3
SCHEMBL340452 0.89 MEN1 (0.84) MEN1KMT2ANR4A2NR4A1NR4A3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 50 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114479101-B Supramolecular gel composition 中北大学 2023-01-17 — — CN claimed
CN-114479101-A Supramolecular gel composition 中北大学 2022-05-13 — — CN claimed
CN-111848939-A Powder coating for engineering machinery, powder resin and preparation method thereof 杭州金质丽科技有限公司 2020-10-30 — — CN claimed
EP-4745634-A1 COMPOSITION, OPTICALLY ANISOTROPIC FILM, AND COMPOUND FUJIFILM Corporation (JP) 2026-05-20 — — EP disclosed
US-20260092215-A1 COMPOSITION, OPTICALLY ANISOTROPIC FILM, AND COMPOUND FUJIFILM CORPORATION (JP) 2026-04-02 — — US disclosed
US-20250375539-A1 COMPOSITIONS OF DISPERSED SYSTEMS FOR BIOMEDICAL APPLICATIONS, PROCESS FOR THEIR PREPARATION AND USES THEREOF SUPERBRANCHE (FR) 2025-12-11 — — US disclosed
US-20250376485-A1 DENDRITIC MOLECULES, PROCESS FOR THEIR PREPARATION AND USES THEREOF SUPERBRANCHE (FR) 2025-12-11 — — US disclosed
WO-2025069643-A1 LIQUID CRYSTAL COMPOSITION, CURED PRODUCT, FILM, AND COMPOUND 富士フイルム株式会社 2025-04-03 — — WO disclosed
EP-4508118-A1 DENDRITIC MOLECULES, PROCESS FOR THEIR PREPARATION AND USES THEREOF Superbranche (FR) 2025-02-19 — — EP disclosed
EP-4507743-A1 COMPOSITIONS OF DISPERSED SYSTEMS FOR BIOMEDICAL APPLICATIONS, PROCESS FOR THEIR PREPARATION AND USES THEREOF Superbranche (FR) 2025-02-19 — — EP disclosed
WO-2025013902-A1 COMPOSITION, OPTICALLY ANISOTROPIC FILM, AND COMPOUND 富士フイルム株式会社 2025-01-16 — — WO disclosed
US-7335751-B2 Aryl carbamate oligomers for hydrolyzable prodrugs and prodrugs comprising same BIOCON LIMITED (IN) 2008-02-26 — — US disclosed
US-7335751-B2 Aryl carbamate oligomers for hydrolyzable prodrugs and prodrugs comprising same BIOCON LIMITED (IN) 2008-02-26 — — US disclosed
WO-2007148822-A1 POLYFUNCTIONAL EPOXY COMPOUND, EPOXY RESIN, CATIONIC PHOTOPOLYMERIZABLE EPOXY RESIN COMPOSITION, MICRO STRUCTURED MEMBER, PRODUCING METHOD THEREFOR AND LIQUID DISCHARGE HEAD CANON KABUSHIKI KAISHA (JP) 2007-12-27 — — WO disclosed
EP-1828147-A1 QUINOXALINES AS B-RAF INHIBITORS AstraZeneca AB (SE) 2007-09-05 — — EP disclosed
WO-2006040568-A1 QUINOXALINES AS B RAF INHIBITORS ASTRAZENECA AB (SE) 2006-04-20 — — WO disclosed
US-6806395-B2 FOR PRODUCING 3,5- DIISOPROPYLPHENOL OR A SIMILAR COMPOUND, WHICH SERVES AS AN INTERMEDIATE FOR PRODUCING ANTI-INFLAMMATORY AGENTS, PESTICIDES, ETC. KOWA CO., LTD. (JP) 2004-10-19 — — US disclosed
US-20040044255-A1 Process for preparation of 3,5-bisalkylphenols KOWA CO., LTD. (JP) 2004-03-04 — — US disclosed
US-5811521-A Multifunctional crosslinking reagents for hemoglobin, and crosslinked hemoglobin conjugates KLUGER RONALD H (CA) 1998-09-22 — — US disclosed
US-4018825-A BRONCHODILATORS WARNER-LAMBERT COMPANY (US) 1977-04-19 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250375539-A1 COMPOSITIONS OF DISPERSED SYSTEMS FOR BIOMEDICAL APPLICATIONS, PROCESS FOR THEIR PREPARATION AND USES THEREOF TLR3, MSR1, DCLRE1B MEN1 4489/4885KMT2A 4857/4885NR4A2 3569/4885
US-20250376485-A1 DENDRITIC MOLECULES, PROCESS FOR THEIR PREPARATION AND USES THEREOF PHOSPHO1, TLR3, CLTB MEN1 2897/4885KMT2A 4514/4885NR4A2 2709/4885
US-20040044255-A1 Process for preparation of 3,5-bisalkylphenols ACSL3, HACL2, ARL1 MEN1 2978/4885KMT2A 2277/4885NR4A2 1478/4885
US-20260092215-A1 COMPOSITION, OPTICALLY ANISOTROPIC FILM, AND COMPOUND SMC1A, SMC2, SMC3 MEN1 209/4885KMT2A 928/4885NR4A2 793/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.